Karyopharm Therapeutics
Price & Volume
Stats
See more52W Range | $3.65-$10.99 |
Market Cap | $180.3M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $146M |
Revenue Growth (YoY) | 11.6% |
Gross Profit (12 Mos) | $14.5M |
Diluted EPS | -$17.93 |
News
See moreYahoo Finance • 20 days ago
JPMorgan BetaBuilders MSCI U.S. REIT ETF declares quarterly distribution of $0.4053
Yahoo Finance • 20 days ago
JPMorgan BetaBuilders International Equity ETF declares quarterly distribution of $0.2556
Yahoo Finance • 5 months ago
Endometrial Cancer Market Poised for Expansion Throughout Forecast Period (2025-2034) Amid Increasing Adoption of Immunotherapies | DelveInsight
Yahoo Finance • 6 months ago
Karyopharm rises on securing $100M in financing to extend cash runway into Q2 2026
About
CEO | Mr. Richard A. Paulson M.B.A. |
CFO | Ms. Lori A. Macomber CPA |
Address | 85 Wells Avenue, Newton, MA, United States, 02459-3298 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 228 |
